MedPath

Observation of clinical efficacy of intrauterine infusion of Danhong injection in adjuvant treatment of intrauterine adhesions

Phase 1
Recruiting
Conditions
Intrauterine adhesions
Registration Number
ITMCTR2000003708
Lead Sponsor
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. The diagnosis is confirmed by hysteroscopy as intrauterine adhesions (according to the classification standard of European Gynecological Endoscopy Association);
2. Women aged 18-40 years;
3. The sex hormone test is normal;
4. The menstrual cycle is normal, and the menstrual volume is significantly less than 1/2 of the previous one, or less than 30ml (menstrual blood loss diagram method);
5. 3 months before the treatment, have not used any hormone drugs, have not used IUD for contraception;
6. Non-pregnant state.

Exclusion Criteria

1. Persons who are allergic to the drugs used in this test;
2. Congenital defects and deformities of the reproductive system;
3. Persons with genital tuberculosis;
4. Mentally ill patients;
5. Combined with serious diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, the operator cannot cooperate to complete the research plan, including patients with a history of infectious diseases, mental illness and other diseases.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hysteroscopy score;Menstrual score;
Secondary Outcome Measures
NameTimeMethod
Endometrial thickness;Endometrial typing;
© Copyright 2025. All Rights Reserved by MedPath